Endoscopic Vessel Harvesting System Market Size & Growth Forecast 2026–2035, By Segments (Product, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Endoscopic Vessel Harvesting System Market size was estimated at USD 162.22 Million in 2025 and is projected to grow at a 3.6% CAGR from 2026 to 2035, crossing USD 231.05 Million by 2035. The industry revenue for 2026 is assessed at USD 167.18 million.

• Base Year Value (2025): USD 162.22 Million
• CAGR (2026-2035): 3.6%
• Forecast Year Value (2035): USD 231.05 Million
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Endoscopic Vessel Harvesting System Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America leads the market with established cardiac surgery volumes, advanced surgical infrastructure, and routine adoption of minimally invasive vessel harvesting technologies across hospitals.
  • Asia Pacific is projected to grow at a 4.1% CAGR as hospitals invest in advanced surgical equipment and expand the adoption of minimally invasive cardiovascular procedures.

• Segment Momentum:

  • Disposable systems lead due to strong infection-control compliance, consistent sterility assurance, and reduced reprocessing burden, making them preferred in routine surgical workflows.
  • PAD is the fastest-growing application as minimally invasive vessel harvesting adoption expands beyond cardiac use, supporting broader vascular interventions requiring efficient conduit preparation.

• Market Expansion Drivers:

  • Rising prevalence of cardiovascular diseases increasing demand for minimally invasive CABG procedures.
  • Advancements in imaging-enabled EVH systems improving surgical precision and patient outcomes.
  • Expanding geriatric population driving long-term growth in coronary bypass surgical interventions.

• Leading Market Participants:

  Prominent players in the endoscopic vessel harvesting system market include Getinge AB (Sweden), Terumo Corporation (Japan), Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), LivaNova PLC (United Kingdom), Saphena Medical, Inc. (United States), MAQUET Holding B.V. & Co. KG (Germany), CARDIO MEDICAL GmbH (Germany), Medical Instruments S.p.A. (Italy), Med Europe S.r.l. (Italy).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 162.22 Million
  • Projected Market Size: USD 231.05 Million by 2035
  • Growth Forecasts: 3.6% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Disposable (Product) | Coronary Artery Disease (CAD) (Application)
  • Emerging Opportunity Segment: Re-usable (Product) | Peripheral Artery Disease (PAD) (Application)

Market Growth Drivers and Industry Trends

Rising prevalence of cardiovascular diseases increasing demand for minimally invasive CABG procedures

As the burden of coronary artery disease rises, hospitals are handling a larger volume of patients who progress from medical management or stenting to coronary artery bypass grafting, which directly increases procedural demand for the endoscopic vessel harvesting system market. Surgeons and cardiac centers are favoring minimally invasive vessel harvesting techniques because they reduce leg wound complications, shorten recovery time, and better align with care pathways focused on faster postoperative mobilization. This transitions purchasing decisions toward EVH platforms that can support higher CABG throughput while helping providers standardize less invasive graft harvesting as part of routine cardiac surgery practice.

Advancements in imaging-enabled EVH systems improving surgical precision and patient outcomes

Imaging-enabled platforms are strengthening the endoscopic vessel harvesting system market by making vessel dissection and side-branch management more controlled during graft retrieval, which matters in CABG procedures where conduit quality directly affects surgical confidence and downstream outcomes. When EVH systems provide clearer visualization and better intraoperative guidance, cardiac surgeons face fewer technical limitations in adopting endoscopic harvesting, and hospitals gain stronger justification for upgrading legacy equipment or expanding EVH use across surgical teams. These technology improvements influence market adoption through practical operating-room benefits: more consistent harvesting performance, smoother training of new users, and reduced hesitation around transitioning from open techniques.

Expanding geriatric population driving long-term growth in coronary bypass surgical interventions

An expanding elderly population is contributing to market size growth in the endoscopic vessel harvesting system market because older patients represent a large share of those requiring revascularization for complex multivessel coronary disease. In practice, this patient group places greater emphasis on surgical approaches that limit wound-related morbidity and support recovery after major cardiac procedures, making endoscopic harvesting more attractive to clinicians managing frailer cases with higher complication sensitivity. As cardiac programs adapt to sustained demand from aging populations, EVH systems become more embedded in bypass surgery workflows, supporting recurring equipment utilization and procurement tied to long-term CABG case volumes.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of cardiovascular diseases increasing demand for minimally invasive CABG procedures	1.90%	High	North America, Europe	High	Near Term
Advancements in imaging-enabled EVH systems improving surgical precision and patient outcomes	1.60%	High	North America, Asia Pacific	Medium	Mid Term
Expanding geriatric population driving long-term growth in coronary bypass surgical interventions	1.30%	Moderate	Europe, North America	High	Long Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest regional share of the endoscopic vessel harvesting system market in 2025, supported by established cardiac surgery volumes, broad familiarity with minimally invasive vessel harvesting techniques, and stronger access to specialized surgical infrastructure. The region’s leadership is reinforced by the routine integration of advanced operating room technologies in hospital settings, where purchasing decisions are closely tied to procedural efficiency, reduced wound complications, and surgeon preference for clinically proven systems. These operating conditions help sustain demand for endoscopic vessel harvesting platforms and related procedural adoption across major care centers.

Asia Pacific is projected to expand at a 4.1% CAGR over the forecast period, with growth in the endoscopic vessel harvesting system market being impelled by the gradual modernization of surgical capabilities and wider uptake of minimally invasive cardiovascular procedures. Adoption is accelerating as hospitals in the region continue investing in advanced surgical equipment and as clinical teams gain greater exposure to techniques that can improve recovery profiles compared with conventional harvesting approaches. The market is also benefiting from a broader shift toward upgrading procedural standards in high-volume urban healthcare centers, where demand tends to build first in practice.

Key Country Insights

United States

Minimally Invasive Cardiac Care

The U.S. endoscopic vessel harvesting system market benefits from broad adoption of minimally invasive cardiac surgery techniques. Hospitals prioritize technologies that improve procedural consistency, reduce surgical trauma, and support faster patient recovery within cardiovascular care programs.

Japan

Precision Surgical Adoption

Japan supports the endoscopic vessel harvesting system market with demand for minimally invasive procedures and advanced operating room technologies. Medical institutions emphasize reliable imaging, surgeon training, and consistent clinical outcomes in cardiovascular interventions.

South Korea

Advanced Hospital Integration

South Korea is strengthening the endoscopic vessel harvesting system market through modernization of cardiac surgery infrastructure. Healthcare providers adopt systems that improve procedural precision, reduce recovery time, and integrate efficiently with minimally invasive surgical workflows.

Germany

Surgical Workflow Optimization

Germany advances the endoscopic vessel harvesting system market through continued investment in precision surgical technologies. Healthcare providers focus on equipment that enhances procedural efficiency, improves graft quality, and supports standardized cardiovascular surgery practices.

France

Clinical Quality Enhancement

France promotes the endoscopic vessel harvesting system market by emphasizing patient-centered surgical care and improved procedural outcomes. Hospitals invest in technologies that minimize tissue damage while supporting efficient cardiovascular surgical practices.

Italy

Cardiac Procedure Efficiency

Italy supports the endoscopic vessel harvesting system market through wider adoption of minimally invasive cardiac surgery techniques. Healthcare facilities prioritize systems that enhance surgical precision, optimize operating room workflows, and improve postoperative recovery experiences.

Segment Leadership and Growth Trends

  Product Segment Analysis: Disposable (Largest Segment) vs Re-usable (Fastest-Growing Segment)

Within the endoscopic vessel harvesting system market, Disposable products held the largest share in 2025, aided by their fit with operating room infection-control protocols and streamlined procedural workflow. Hospitals and surgical teams often prefer single-use systems when consistency, sterility assurance, and reduced reprocessing burden matter most in vessel harvesting procedures. That practical advantage helps Disposable products maintain leadership in the endoscopic vessel harvesting system market, particularly where providers aim to minimize turnaround complexity between cases.

Re-usable products are emerging as the fastest-growing segment in the endoscopic vessel harvesting system market as healthcare facilities place greater emphasis on equipment utilization and long-term procedural economics. Their momentum is being aided by buyers willing to invest in systems that can be used across repeated procedures when sterilization infrastructure and device management processes are already in place. Compared with Disposable alternatives, Re-usable systems are gaining traction where procurement decisions are increasingly shaped by lifecycle cost considerations rather than single-procedure convenience.

Application Segment Analysis: Coronary Artery Disease (CAD) (Largest Segment) vs Peripheral Artery Disease (PAD) (Fastest-Growing Segment)

Coronary Artery Disease (CAD) accounted for the largest share of the endoscopic vessel harvesting system market in 2025, reflecting the established use of vessel harvesting in cardiac bypass procedures. Its leadership is underpinned by the routine integration of endoscopic harvesting techniques into coronary revascularization settings, where surgical teams prioritize reliable conduit retrieval and procedural familiarity. This entrenched clinical use keeps CAD at the center of demand in the endoscopic vessel harvesting system market.

Peripheral Artery Disease (PAD) is the fastest-growing application in the endoscopic vessel harvesting system market as treatment activity expands beyond traditional cardiac settings into broader vascular intervention pathways. Growth is being influenced by increasing procedural adoption in cases where minimally invasive vessel harvesting offers practical value for peripheral bypass preparation. Relative to CAD, PAD is growing from a less mature base, which allows adoption gains to translate more quickly into segment expansion.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Disposable, Re-usable	Disposable	Re-usable
Application	Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD)	Coronary Artery Disease (CAD)	Peripheral Artery Disease (PAD)

Competitive Landscape and Market Positioning

Leading companies in the endoscopic vessel harvesting system market:

1. Getinge AB (Sweden)

2. Terumo Corporation (Japan)

3. Olympus Corporation (Japan)

4. KARL STORZ SE & Co. KG (Germany)

5. LivaNova PLC (United Kingdom)

6. Saphena Medical Inc. (United States)

7. MAQUET Holding B.V. & Co. KG (Germany)

8. CARDIO MEDICAL GmbH (Germany)

9. Medical Instruments S.p.A. (Italy)

10. Med Europe S.r.l. (Italy)

Surgical precision requirements are driving steady evolution in the endoscopic vessel harvesting system market, where minimally invasive approaches are becoming increasingly central to procedural advancement. Device refinement is focused on improving harvesting efficiency while reducing patient trauma. In the endoscopic vessel harvesting system market, continuous innovation in visualization and instrumentation is strengthening surgical outcomes and procedural reliability.

Industry Development/News

Company Name	Date	Key Development
Getinge	Mar-24	Getinge obtained U.S. FDA 510(k) clearance for its Vasoview Hemopro 3 Endoscopic Vessel Harvesting system, strengthening its minimally invasive cardiovascular surgery portfolio. The approval is positioned to expand clinical adoption by enhancing surgical efficiency and reinforcing the company’s regulatory footprint in EVH technologies.
Getinge	May-24	Getinge organized a Vessel Harvesting (EVH) Summit in Singapore, bringing together clinicians to discuss surgical ergonomics, patient considerations, and procedural best practices. The initiative supports clinical engagement and knowledge exchange, reinforcing Getinge’s ecosystem positioning within endoscopic vessel harvesting procedures.
COMBINE-CT	Dec-23	COMBINE-CT received USD 7.28 million in funding from the Innovative Health Initiative to advance diagnostic and treatment approaches for coronary artery disease. The initiative is expected to improve clinical accuracy and treatment pathways, indirectly supporting demand for advanced cardiovascular and endoscopic vessel harvesting procedures.
LivaNova PLC	Apr-22	LivaNova PLC introduced the Essenz Patient Monitor in the U.S. and Europe following FDA 510(k) clearance and CE Mark approval. The system is designed to enhance cardiopulmonary bypass procedures through patient-tailored monitoring, improving clinical efficiency in cardiovascular surgical workflows associated with vessel harvesting procedures.
CardioPrecision	Sep-21	CardioPrecision launched its CoreVista device suite for use in endoscopic vessel harvesting during coronary artery bypass grafting procedures. The introduction expands minimally invasive surgical tool availability, supporting procedural efficiency and contributing to broader adoption of EVH techniques in cardiac surgery environments.
Getinge / Maquet	2024	Getinge’s Maquet division experienced a Class I recall of its VasoView HemoPro endoscopic vessel harvesting device due to risks linked to silicone debris-related injuries. The incident triggered FDA communication on potential device shortages, highlighting regulatory and supply continuity risks impacting EVH system availability in cardiovascular surgical applications.